Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 7:49 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 865–888 of 1,743 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Cardiovascular Risks Clear all

Conditions: Thrombosis
Interventions: Heparin; Drug
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 1,015 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2012
U.S. locations: 4
States / cities: Rochester, Minnesota • Chapel Hill, North Carolina • Durham, North Carolina + 1 more

Conditions: Atherosclerosis
Interventions: Not listed
Lead sponsor: Ohio State University; Other
Eligibility: 40 Years and older · Female only
Enrollment: 177 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2018
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Mood Disorders, Hypertension, Overweight and Obesity, Vascular Stiffness, Sleep, Elevated Blood Pressure
Interventions: Cardiovascular Assessments, Actigraphy, Laboratory assessments, Emotional/ Behavioural assessments; Diagnostic Test · Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: Up to 22 Years
Enrollment: 37 participants
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: PreDiabetes
Interventions: PAC with HEPA filter intact, PAC with HEPA filter removed; Device
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 85 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: New York, New York

Conditions: Obesity, Body Composition, Blood Pressure, Cardiovascular Diseases
Interventions: low carbohydrate diet, low fat diet; Behavioral
Lead sponsor: Tulane University Health Sciences Center; Other
Eligibility: 22 Years to 75 Years
Enrollment: 148 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2012
U.S. locations: 1
States / cities: New Orleans, Louisiana

Conditions: Heart Failure
Interventions: WiSE System; Device
Lead sponsor: EBR Systems, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2027
U.S. locations: 43
States / cities: Huntsville, Alabama • La Jolla, California • Fort Lauderdale, Florida + 37 more

Conditions: Cardiovascular Diseases
Interventions: Telmisartan, Combination of Telmisartan and Ramipril, Ramipril; Drug
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 55 Years and older
Enrollment: 31,546 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2001
U.S. locations: 100
States / cities: Athens, Alabama • Birmingham, Alabama • Phoenix, Arizona + 84 more

Conditions: Cardiovascular Diseases
Interventions: Digitally delivered gardening and healthy eating course; Behavioral
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 20 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: Cardiovascular Diseases, Heart Diseases, Obesity, Metabolic Syndrome X
Interventions: Not listed
Lead sponsor: Emory University; Other
Eligibility: 30 Years to 78 Years
Enrollment: 4,024 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2009
U.S. locations: 2
States / cities: Atlanta, Georgia

Conditions: Pulmonary Disease, Chronic Obstructive
Interventions: fluticasone furoate/vilanterol, fluticasone furoate, vilanterol, Placebo; Drug · Other
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 40 Years to 80 Years
Enrollment: 16,568 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 506
States / cities: Andalusia, Alabama • Athens, Alabama • Birmingham, Alabama + 369 more

Conditions: Obesity, Type 2 Diabetes, Cardiovascular Diseases, Acute Exercise
Interventions: Acute exercise; Behavioral
Lead sponsor: East Carolina University; Other
Eligibility: 18 Years to 30 Years · Male only
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: West Lafayette, Indiana

Conditions: Diabetes Mellitus, Type 2, Cardiovascular Diseases
Interventions: Enrollment in existing SDRI diabetes education programs; Behavioral
Lead sponsor: Sansum Diabetes Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 750 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Santa Barbara, California

Conditions: Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelogenous, Chronic, Multiple Myeloma
Interventions: Dynamic contrast-enhanced computed tomography, Ioversol; Radiation · Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 20 Years to 60 Years
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Myeloma, Plasma-Cell, Myeloma-Multiple, Myelomatosis
Interventions: Adoptive Immunotherapy, Rapamycin-Generated Autologous Th1/Tc1 Cells (modified primary human T cells), Th1/Tc1 Rapa Cell Therapy; Procedure · Biological
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years to 75 Years
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2017
U.S. locations: 2
States / cities: Bethesda, Maryland • Hackensack, New Jersey

Conditions: Acute Myocardial Infarction (AMI)
Interventions: Not listed
Lead sponsor: Montefiore Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 57 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Healthy
Interventions: Not listed
Lead sponsor: Kara Whitaker; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2025
U.S. locations: 3
States / cities: Iowa City, Iowa • Pittsburgh, Pennsylvania • Morgantown, West Virginia

Conditions: Dyslipidemia, Overweight and Obesity, Nutrition, Healthy
Interventions: CSO-30, CSO-20, Control; Other
Lead sponsor: University of Georgia; Other
Eligibility: 25 Years to 75 Years
Enrollment: 75 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Athens, Georgia

Conditions: Cardiometabolic Health
Interventions: Not listed
Lead sponsor: Arkansas Children's Hospital Research Institute; Other
Eligibility: 13 Years to 21 Years
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 2
States / cities: Little Rock, Arkansas

Conditions: Prostate Cancer
Interventions: Diabetes Prevention Program; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older · Male only
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2012
U.S. locations: 3
States / cities: Boston, Massachusetts

Conditions: Obesity, Overweight
Interventions: Tirzepatide, Semaglutide; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 100,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Arteriosclerosis
Interventions: clopidogrel (SR25990); Drug
Lead sponsor: Sanofi; Industry
Eligibility: 45 Years and older
Enrollment: 15,603 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2005
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Aneurysm Cerebral
Interventions: Observation; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Hypercholesterolemia
Interventions: Atorvastatin, Ezetimibe, Alirocumab, Placebo; Drug
Lead sponsor: Regeneron Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 314 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2017
U.S. locations: 41
States / cities: Anaheim, California • Beverly Hills, California • Mission Viejo, California + 38 more

Conditions: Obesity, Type 2 Diabetes, Cardiovascular Risk, Cancer
Interventions: Nutrition, Strength Training & Nutrition, Circuit Training & Nutrition; Behavioral
Lead sponsor: University of Southern California; Other
Eligibility: 14 Years to 18 Years
Enrollment: 104 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: Los Angeles, California

Search by objective public record fields.

Risk of Developing Antibodies to Heparin-PF4 After Heart Surgery

Longitudinal Study in Perimenopausal Women With Risk Factors for Atherosclerosis

Association of Mood With Risk for Atherosclerosis

Cleaner Air for Lower Cardiometabolic Risk

Study of Macronutrients and Heart Disease Risk

Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients

Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.

Growing Healthy Hearts: An Online Gardening Program for Adults With Risk Factors for Cardiovascular Disease

Partnership Programs to Reduce Ethnic Differences in the Risk of Cardiovascular Disease

Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease

Epigenetic Effects of a Single Bout of Exercise on Cardiovascular Risk Factors and the Metabolome

Integrating Abbott Point-of-Care Technologies and the Community Scientist Model to Support HbA1c Testing Per ADA

Abdominal CT to Predict the Risk of Acute Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation

Th1/Tc1 Immunotherapy Following Stem Cell Transplantation in Multiple Myeloma

Risk Stratification After Acute Myocardial Infarction With Cardiac MRI

The Pregnancy 24/7 Cohort Study

Intermittent Cottonseed Oil Consumption

Trajectory Study: Predicting Cardiometabolic Health in Adolescents and Young Adults Based on Childhood Fitness, Sleep, and Diet

Lifestyle Intervention to Improve Insulin Sensitivity and Markers of Cardiovascular Risk in Prostate Cancer Survivors

Tirzepatide vs Semaglutide in Individuals at Cardiovascular Risk But Without Diabetes.

Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA)

Perioperative Risk in Patients on Chronic Aspirin Undergoing Craniotomy

Study of Alirocumab (REGN727/SAR236553) in Patients With Primary Hypercholesterolemia and Moderate, High, or Very High Cardiovascular (CV) Risk, Who Are Intolerant to Statins (ODYSSEY ALTERNATIVE)

Strength and Nutrition Outcomes for Latino Adolescents